Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
90 studies found for:    "Liposarcoma"
Show Display Options
RSS Create an RSS feed from your search for:
"Liposarcoma"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting Assessment of Helical Tomotherapy Radiotherapy (54 Gy) Followed by Surgery in Retro-peritoneal Liposarcoma
Condition: Liposarcoma
Intervention: Radiation: Radiotherapy
2 Unknown  Brostallicin Clinical Trial for Myxoid Liposarcoma
Condition: Myxoid Liposarcoma
Intervention: Drug: Brostallicin
3 Suspended Ph II Cabazitaxel DD Liposarcoma
Condition: Dedifferentiated Liposarcoma
Interventions: Drug: Cabazitaxel;   Drug: Prolonged infusional ifosfamide
4 Recruiting Study of Safety and Efficacy of HDM201 in Combination With LEE011 in Patients With Liposarcoma
Condition: Liposarcoma
Interventions: Drug: HDM201;   Drug: LEE011
5 Recruiting Selinexor in Advanced Liposarcoma
Condition: Dedifferentiated Liposarcoma
Interventions: Drug: Selinexor;   Drug: Placebo
6 Completed
Has Results
Safety and Efficacy Study of Trabectedin for the Treatment of Localized Myxoid / Round Cell Liposarcoma
Condition: Liposarcoma,Myxoid
Interventions: Drug: Trabectedin;   Drug: Dexamethasone
7 Recruiting Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery
Condition: Liposarcoma
Intervention: Drug: efatutazone
8 Recruiting Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcomas
Condition: Myxoid Liposarcoma of Soft Tissue
Intervention: Radiation: dose reduction of preoperative radiotherapy in MLS
9 Completed
Has Results
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
Conditions: Liposarcoma;   Surgically Unresectable Liposarcoma;   Metastatic Liposarcoma
Intervention: Drug: pazopanib
10 Recruiting MGCD516 in Advanced Liposarcoma and Other Soft Tissue Sarcomas
Conditions: Liposarcoma;   Metastatic Liposarcoma
Intervention: Drug: MGCD516
11 Withdrawn Study Evaluating the Efficacy and Safety of IPI 504 in Patients With Advanced Dedifferentiated Liposarcoma
Condition: Dedifferentiated Liposarcoma
Intervention: Drug: IPI-504
12 Active, not recruiting Activity and Tolerability of Pazopanib in Advanced and/or Metastatic Liposarcoma. A Phase II Clinical Trial
Condition: Advanced and / or Metastatic Liposarcoma
Intervention: Drug: Pazopanib
13 Recruiting Efficacy Study on Trabectedin in Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma
Conditions: Liposarcoma;   Leiomyosarcoma
Intervention: Drug: Trabectedin
14 Completed
Has Results
A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma
Condition: Advanced Liposarcoma or Leiomyosarcoma
Interventions: Drug: Trabectedin;   Drug: Dacarbazine
15 Active, not recruiting A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma
Condition: Advanced or Metastatic Liposarcoma or Leiomyosarcoma
Interventions: Drug: Trabectedin;   Drug: Dacarbazine
16 Terminated Efficacy and Safety of Plitidepsin in Patients With Advanced Unresectable or Metastatic, Relapsed/Refractory, Dedifferentiated Liposarcoma (DLPS): an Exploratory Phase II Multicenter Trial
Condition: Adult Patients With Unresectable Locally Advanced or Metastatic, Relapsed/Refractory Dedifferentiated Liposarcoma
Intervention: Drug: plitidepsin
17 Completed PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma
Conditions: Sarcoma;   Liposarcoma
Intervention: Drug: Palbociclib
18 Recruiting Study of Abemaciclib in Dedifferentiated Liposarcoma
Conditions: Sarcoma;   Dedifferentiated Liposarcoma
Intervention: Drug: Abemaciclib
19 Active, not recruiting A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma
Conditions: Liposarcoma;   Soft Tissue Sarcoma
Intervention: Drug: ribociclib
20 Active, not recruiting A Trial of Oral 5-azacitidine in Combination With Romidepsin in Advanced Solid Tumors, With an Expansion Cohort in Virally Mediated Cancers and Liposarcoma
Conditions: Solid Tumors;   Virally Mediated Cancers and Liposarcoma
Intervention: Drug: oral 5-azacitidine in combination with romidepsin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.